2m 2m 2m 2m 2m 2m 2m
KYVERNA THERAP (KYTX)
NASDAQ
$5.83-$0.01 (-0.26%)
Price as of Oct 22, 2026 7:49 PM EDT- $361.2MMarket Cap
- -12.44%1-Year Change
- BiotechnologyIndustry
KYVERNA THERAP (KYTX)
$5.83-$0.01 (-0.26%)
KYTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.84 | ||
Change | -$0.20 (-3.31%) | ||
Open | $6.15 | ||
High | $6.30 | ||
Low | $5.80 | ||
Previous Close | $6.04 | ||
Volume | 822,940 | ||
30-Day Average Volume | 1,006,174 | ||
1-Week Change | 2.73% | ||
1-Month Change | -17.98% | ||
1-Year Change | -12.44% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 61.8M | ||
Total Assets | $219.8M | ||
Market Cap | $361.2M | ||
Enterprise Value | $354.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$38.3M | ||
Free Cash Flow | -$40.3M | ||
EBIT | -$37.6M | ||
EBITDA | -$37.2M | ||
Net Working Capital | $183.7M | ||
EPS | -$0.63 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -9 | ||
PEG | -2 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue